Cargando…

Bevacizumab Treatment of Radiation-Induced Brain Necrosis: A Systematic Review

BACKGROUND: Radiation brain necrosis (RBN) is a serious complication in patients receiving radiotherapy for intracranial disease. Many studies have investigated the efficacy and safety of bevacizumab in patients with RBN. In the present study, we systematically reviewed the medical literature for st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Guixiang, Khan, Muhammad, Zhao, Zhihong, Arooj, Sumbal, Yan, Maosheng, Li, Xianming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027305/ https://www.ncbi.nlm.nih.gov/pubmed/33842309 http://dx.doi.org/10.3389/fonc.2021.593449

Ejemplares similares

Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis
por: Khan, Muhammad, et al.
Publicado: (2021)

Radiation Plus Anti-PD-1 Therapy for NSCLC Brain Metastases: A Retrospective Study
por: Liao, Guixiang, et al.
Publicado: (2021)

Impact of Tyrosine Kinase Inhibitors (TKIs) Combined With Radiation Therapy for the Management of Brain Metastases From Renal Cell Carcinoma
por: Khan, Muhammad, et al.
Publicado: (2020)

Lapatinib Plus Local Radiation Therapy for Brain Metastases From HER-2 Positive Breast Cancer Patients and Role of Trastuzumab: A Systematic Review and Meta-Analysis
por: Khan, Muhammad, et al.
Publicado: (2020)

Efficacy of BRAF Inhibitors in Combination With Stereotactic Radiosurgery for the Treatment of Melanoma Brain Metastases: A Systematic Review and Meta-Analysis
por: Khan, Muhammad, et al.
Publicado: (2021)

Impact of Previous Local Treatment for Brain Metastases on Response to Molecular Targeted Therapy in BRAF-Mutant Melanoma Brain Metastasis: A Systematic Review and Meta-Analysis
por: Liao, Guixiang, et al.
Publicado: (2022)

Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy
por: Khan, Muhammad, et al.
Publicado: (2020)

Efficacy and Safety of Hypofractionated Radiotherapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme: A Systematic Review and Meta-Analysis
por: Liao, Guixiang, et al.
Publicado: (2019)

Anti-PD1 Therapy Plus Whole-Brain Radiation Therapy May Prolong PFS in Selected Non–Small Cell Lung Cancer Patients with Brain Metastases: A Retrospective Study
por: Khan, Muhammad, et al.
Publicado: (2021)

Bevacizumab Combined with Corticosteroids Does Not Improve the Clinical Outcome of Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis
por: Li, Honghong, et al.
Publicado: (2021)

Blood–Brain Barrier Repair of Bevacizumab and Corticosteroid as Prediction of Clinical Improvement and Relapse Risk in Radiation-Induced Brain Necrosis: A Retrospective Observational Study
por: Xue, Ruiqi, et al.
Publicado: (2021)

Whole Brain Radiation Therapy Plus Stereotactic Radiosurgery in the Treatment of Brain Metastases Leading to Improved Survival in Patients With Favorable Prognostic Factors
por: Khan, Muhammad, et al.
Publicado: (2019)

Prognostic Role of Soluble Programmed Death Ligand 1 in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Liao, Guixiang, et al.
Publicado: (2021)

Efficacy and Safety of Actively Personalized Neoantigen Vaccination in the Management of Newly Diagnosed Glioblastoma: A Systematic Review
por: Khan, Muhammad, et al.
Publicado: (2021)

Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues
por: Zhuang, Hongqing, et al.
Publicado: (2019)

Tumor Primary Site and Histology Subtypes Role in Radiotherapeutic Management of Brain Metastases
por: Khan, Muhammad, et al.
Publicado: (2020)

Bevacizumab for the Treatment of Radiation-Induced Cerebral Necrosis: A Systematic Review of the Literature
por: Delishaj, Durim, et al.
Publicado: (2017)

High-dose bevacizumab for radiation-induced brain necrosis: a case report
por: Panagiotou, Emmanouil, et al.
Publicado: (2023)

Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation
por: Zhuang, Hongqing, et al.
Publicado: (2016)

Clinical Experience of Bevacizumab for Radiation Necrosis in Patients with Brain Metastasis
por: Park, Moowan, et al.
Publicado: (2020)

Low-Dose Bevacizumab Is Effective in Radiation-Induced Necrosis
por: Alessandretti, Matheus, et al.
Publicado: (2013)

Diagnosis and Management of Radiation Necrosis in Patients With Brain Metastases
por: Vellayappan, Balamurugan, et al.
Publicado: (2018)

Honokiol ameliorates radiation-induced brain injury via the activation of SIRT3
por: Liao, Guixiang, et al.
Publicado: (2020)

Restriction-Spectrum Imaging of Bevacizumab-Related Necrosis in a Patient with GBM
por: Farid, Nikdokht, et al.
Publicado: (2013)

Acquired-resistance of bevacizumab treatment for radiation brain necrosis: a case report
por: Zhuang, Hongqing, et al.
Publicado: (2016)

Inflammation as well as angiogenesis may participate in the pathophysiology of brain radiation necrosis
por: Yoritsune, Erina, et al.
Publicado: (2014)

Comparative analysis of robotic gastrectomy and laparoscopic gastrectomy for gastric cancer in terms of their long-term oncological outcomes: a meta-analysis of 3410 gastric cancer patients
por: Liao, Guixiang, et al.
Publicado: (2019)

Case Report: Radiotherapy Plus Immunotherapy and Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma With a Right Atrium and Inferior Vena Cava Tumor Thrombus
por: Qian, Yuting, et al.
Publicado: (2022)

Neutrophil to lymphocyte ratio as a predictor for treatment of radiation‐induced brain necrosis with bevacizumab in nasopharyngeal carcinoma patients
por: Cai, Jinhua, et al.
Publicado: (2022)

Effect of bevacizumab on brain radiation necrosis in anaplastic lymphoma kinase‐positive lung cancer
por: Tanigawa, Kengo, et al.
Publicado: (2019)

Treatment of Radiation-Induced Brain Necrosis
por: Yang, Xiaojing, et al.
Publicado: (2021)

Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients
por: Wang, Yang, et al.
Publicado: (2012)

Low-Dosage Bevacizumab Treatment: Effect on Radiation Necrosis After Gamma Knife Radiosurgery for Brain Metastases
por: Weng, Yuxiang, et al.
Publicado: (2021)

NK Cell-Based Immune Checkpoint Inhibition
por: Khan, Muhammad, et al.
Publicado: (2020)

Soluble B7-CD28 Family Inhibitory Immune Checkpoint Proteins and Anti-Cancer Immunotherapy
por: Khan, Muhammad, et al.
Publicado: (2021)

Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma
por: Vaios, Eugene J., et al.
Publicado: (2022)

MLTI-06. BEVACIZUMAB VERSUS SURGICAL INTERVENTION FOR RADIATION NECROSIS IN PREVIOUSLY IRRADIATED BRAIN METASTASES
por: Hong, Christopher, et al.
Publicado: (2019)

Brain Radiation Necrosis: Current Management With a Focus on Non-small Cell Lung Cancer Patients
por: Loganadane, Gokoulakrichenane, et al.
Publicado: (2018)

FSRT vs. SRS in Brain Metastases—Differences in Local Control and Radiation Necrosis—A Volumetric Study
por: Putz, Florian, et al.
Publicado: (2020)

Radiation Necrosis in Intracranial Lesions
por: Munier, Sean, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gpnh0s1kjrr7g3mb05fkm220ph